English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Article details
Italfarmaco Group Announces Positive Topline Data from Phase 3 Trial Showing Beneficial Effect of Givinostat in Patients with Duchenne Muscular Dystrophy
Created by superuser on 6/27/2022 4:20:14 PM


print
Sort by: